Iodide

Iodide

SCHEMBL354263

CN1CN(C)c2ccccc21.I

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
GAA P10253 4/20 0.58
HPGD P15428 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MAPT P10636 1/20 0.58
MAOA P21397 1/20 0.39
CES1 P23141 2/20 0.38
BCHE P06276 1/20 0.38
ADRA2C P18825 1/20 0.37
TLR9 Q9NR96 1/20 0.36
LMNA P02545 1/20 0.36
PAX8 Q06710 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MGLL Q99685 1/20 0.34
TTR P02766 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
CDK4 P11802 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL30935723 1.00 ALDH1A1 (0.58) ALDH1A1GAAHPGDKDM4EMAPT
SCHEMBL178983 0.97 ALDH1A1 (0.61) ALDH1A1GAAHPGDKDM4EMAPT
SCHEMBL29444128 0.97 ALDH1A1 (0.61) ALDH1A1GAAHPGDKDM4EMAPT
Hydrochloric Acid SCHEMBL5146630 0.94 ALDH1A1 (0.58) ALDH1A1GAAHPGDKDM4EMAPT
Lithium SCHEMBL31260774 0.94 ALDH1A1 (0.58) ALDH1A1GAAHPGDKDM4EMAPT
Bromide SCHEMBL9328396 0.94 ALDH1A1 (0.58) ALDH1A1GAAHPGDKDM4EMAPT
Bromide SCHEMBL31722794 0.94 ALDH1A1 (0.58) ALDH1A1GAAHPGDKDM4EMAPT
SCHEMBL28323508 0.87 ALDH1A1 (0.52) ALDH1A1GAAHPGDKDM4EMAPT
SCHEMBL15763560 0.83 ALDH1A1 (0.48) ALDH1A1GAAHPGDKDM4EMAPT
Acetic Acid SCHEMBL29250276 0.83 GAA (0.48) ALDH1A1GAAHPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0398358-B1 Aluminum electroplating method MITSUBISHI PETROCHEMICAL CO (JP) 1994-03-09 EP claimed
US-5041194-A Using low melting mixture of aluminum halide and onium halide of nitrogen-containing compound MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-08-20 US claimed
EP-0398358-A2 Aluminum electroplating method MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-11-22 EP claimed
US-12623250-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2026-05-12 US disclosed
US-12409473-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2025-09-09 US disclosed
WO-2024261685-A1 HARDENING COMPOSITION BASED ON RENEWABLE RAW MATERIALS ECOPOX GMBH & CO. KG (DE) 2024-12-26 WO disclosed
EP-4480983-A1 CURING COMPOSITION BASED ON RENEWABLE RAW MATERIALS ECOPOX GmbH & Co. KG (DE) 2024-12-25 EP disclosed
US-20240351063-A1 Carbene-Functionalized Composite Materials THE UNIVERSITY OF WESTERN ONTARIO (CA) 2024-10-24 US disclosed
US-20240173741-A1 Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2024-05-30 US disclosed
US-11840766-B2 Etching metal using N-heterocyclic carbenes QUEEN'S UNIVERSITY AT KINGSTON (CA) 2023-12-12 US disclosed
US-11801528-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2023-10-31 US disclosed
US-20110257678-A1 VASCULAR EMBOLIC FILTER EXCHANGE DEVICES AND METHODS OF USE THEREOF INCEPT LLC (US) 2011-10-20 US disclosed
US-20110059954-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-10 US disclosed
US-6337305-B1 HERBICIDES FOR AGRICULTURE BASF AKTIENGESELLSCHAFT (DE) 2002-01-08 US disclosed
EP-0398358-B1 Aluminum electroplating method MITSUBISHI PETROCHEMICAL CO (JP) 1994-03-09 EP disclosed
US-5041194-A Using low melting mixture of aluminum halide and onium halide of nitrogen-containing compound MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-08-20 US disclosed
EP-0126231-B1 VINYLPHENYL BENZIMIDAZOLE DERIVATIVES, THEIR POLYMERS, THEIR PREPARATION AND USE Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1989-12-20 EP disclosed
US-4533678-A BENZIMIDAZOLYLSTYRENE POLYMERS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-08-06 US disclosed
EP-0126231-A2 Vinylphenyl benzimidazole derivatives, their polymers, their preparation and use Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-11-28 EP disclosed
US-4035395-A Process for the preparation of ketones BAYER AKTIENGESELLSCHAFT (DT) 1977-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059954-A1 CGRP ANTAGONISTS CALCRL, CALCR, CALCA ALDH1A1 1292/4885GAA 3559/4885HPGD 759/4885
US-12623250-B2 Carbene-functionalized composite materials EPCAM, CAD, CTTN ALDH1A1 527/4885GAA 4628/4885HPGD 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.